SW
TMO icon

SlateStone Wealth’s Thermo Fisher Scientific TMO Stock Holding History

SlateStone Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74M Sell
7,464
-629
-8% -$302K 0.29% 80
2026
Q1 		$3.98M Buy
8,093
+601
+8% +$326K 0.33% 74
2025
Q4 		$4.34M Sell
7,492
-31
-0.4% -$17.5K 0.36% 71
2025
Q3 		$3.65M Buy
7,523
+18
+0.2% +$8.38K 0.32% 78
2025
Q2 		$3.04M Buy
7,505
+484
+7% +$202K 0.28% 84
2025
Q1 		$3.49M Buy
7,021
+349
+5% +$189K 0.35% 75
2024
Q4 		$3.47M Buy
6,672
+524
+9% +$288K 0.34% 79
2024
Q3 		$3.8M Buy
6,148
+279
+5% +$165K 0.34% 75
2024
Q2 		$3.25M Buy
5,869
+767
+15% +$439K 0.35% 70
2024
Q1 		$2.96M Buy
5,102
+277
+6% +$155K 0.3% 78
2023
Q4 		$2.56M Sell
4,825
-1,626
-25% -$787K 0.33% 75
2023
Q3 		$3.27M Buy
6,451
+768
+14% +$409K 0.47% 58
2023
Q2 		$2.96M Sell
5,683
-142
-2% -$76.6K 0.56% 38
2023
Q1 		$3.36M Buy
5,825
+1,948
+50% +$1.1M 0.7% 34
2022
Q4 		$2.14M Buy
3,877
+1,209
+45% +$641K 0.52% 39
2022
Q3 		$1.35M Buy
2,668
+282
+12% +$158K 0.36% 58
2022
Q2 		$1.3M Buy
2,386
+792
+50% +$436K 0.33% 61
2022
Q1 		$941K Buy
+1,594
New +$916K 0.21% 80
2019
Q4 		– Sell
-842
Closed -$245K – 225
2019
Q3 		$245K Sell
842
-90
-10% -$25.8K 0.07% 148
2019
Q2 		$274K Sell
932
-50
-5% -$13.8K 0.08% 148
2019
Q1 		$269K Buy
+982
New +$244K 0.08% 141

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

SlateStone Wealth's TMO Position: Q2 2026 in Review

SlateStone Wealth reduced its Thermo Fisher Scientific (TMO) stake by 7.8% in Q2 2026, selling an estimated $302K and leaving 7,464 shares worth $3.74M. The position accounts for 0.29% of the portfolio, ranked #80.

SlateStone Wealth first reported a position in TMO in Q1 2019 and has held it in 21 quarters since. The position peaked at $4.34M in Q4 2025. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SlateStone Wealth held 7,464 shares of Thermo Fisher Scientific worth $3.74M as of Q2 2026.
  • SlateStone Wealth sold 629 Thermo Fisher Scientific shares in Q2 2026, an estimated $302K.
  • Thermo Fisher Scientific made up 0.29% of SlateStone Wealth's portfolio in Q2 2026, its #80 holding.
  • SlateStone Wealth first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 21 quarters since.
  • SlateStone Wealth's Thermo Fisher Scientific position peaked at $4.34M in Q4 2025.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.